Trial Profile
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2022
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms IFN free SL study
- 14 Dec 2015 New trial record